Entellus Medical Raises $30 Million
Entellus Medical Inc., a Maple Grove, Minn.-based developer of a system for treating chronic sinusitis, has raised $30 million in Series D funding. Essex Woodlands Health Ventures led the round, and was joined by return backers Split Rock Partners and SV Life Sciences. Montagu Newhall Associates, which led the company's $15 million Series C round, was not listed as a Series D participant.
17 November 2009•3 mins read
